These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33602926)

  • 41. Perturbation of microbiota in one-day old broiler chickens with antibiotic for 24 hours negatively affects intestinal immune development.
    Schokker D; Jansman AJ; Veninga G; de Bruin N; Vastenhouw SA; de Bree FM; Bossers A; Rebel JM; Smits MA
    BMC Genomics; 2017 Mar; 18(1):241. PubMed ID: 28320307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
    Chuang YM; Dutta NK; Gordy JT; Campodónico VL; Pinn ML; Markham RB; Hung CF; Karakousis PC
    Front Immunol; 2020; 11():680. PubMed ID: 32411131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.
    Pavan Kumar N; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Shanmugam S; Hissar S; Kornfeld H; Babu S
    Front Cell Infect Microbiol; 2019; 9():335. PubMed ID: 31632923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
    Khaliq A; Ravindran R; Afzal S; Jena PK; Akhtar MW; Ambreen A; Wan YY; Malik KA; Irfan M; Khan IH
    PLoS One; 2021; 16(1):e0245534. PubMed ID: 33481833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
    PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relapse of tuberculosis versus primary tuberculosis; course, pathogenesis and therapy in mice.
    de Steenwinkel JE; de Knegt GJ; ten Kate MT; Verbrugh HA; Hernandez-Pando R; Leenen PJ; Bakker-Woudenberg IA
    Tuberculosis (Edinb); 2013 Mar; 93(2):213-21. PubMed ID: 23266260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of whole-blood interferon-γ and flow cytometry assays for detecting post-treatment immune responses in patients with active tuberculosis.
    Kim CH; Choi KJ; Yoo SS; Lee SY; Won DI; Lim JO; Cha SI; Park JY; Lee J
    Cytometry B Clin Cytom; 2014 Jul; 86(4):236-43. PubMed ID: 23959689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
    Hawn TR; Shah JA; Kalman D
    Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TB drug development: immunology at the table.
    Nathan C; Barry CE
    Immunol Rev; 2015 Mar; 264(1):308-18. PubMed ID: 25703568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.
    Sander MS; Vuchas CY; Numfor HN; Nsimen AN; Abena JL; Noeske J; Van Deun A; Morgan KL
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):793-9. PubMed ID: 27155183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term effects of early life microbiota disturbance on adaptive immunity in laying hens.
    Simon K; Verwoolde MB; Zhang J; Smidt H; de Vries Reilingh G; Kemp B; Lammers A
    Poult Sci; 2016 Jul; 95(7):1543-1554. PubMed ID: 26976906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiome Alteration in Lung Tissues of Tuberculosis Patients Revealed by Metagenomic Next-Generation Sequencing and Immune-Related Transcriptional Profile Identified by Transcriptome Sequencing.
    Liu H; Ji S; Fang Y; Yi X; Wu F; Xing F; Wang C; Zhou H; Xu J; Sun W
    ACS Infect Dis; 2023 Dec; 9(12):2572-2582. PubMed ID: 37975314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
    Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
    Front Immunol; 2020; 11():36. PubMed ID: 32117228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.
    Marimani M; Ahmad A; Duse A
    Tuberculosis (Edinb); 2018 Dec; 113():200-214. PubMed ID: 30514504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells.
    Saharia KK; Petrovas C; Ferrando-Martinez S; Leal M; Luque R; Ive P; Luetkemeyer A; Havlir D; Koup RA
    PLoS One; 2016; 11(7):e0158262. PubMed ID: 27367521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression profiles classifying clinical stages of tuberculosis and monitoring treatment responses in Ethiopian HIV-negative and HIV-positive cohorts.
    Gebremicael G; Kassa D; Alemayehu Y; Gebreegziaxier A; Kassahun Y; van Baarle D; H M Ottenhoff T; M Cliff J; C Haks M
    PLoS One; 2019; 14(12):e0226137. PubMed ID: 31821366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heterogeneity in tuberculosis.
    Cadena AM; Fortune SM; Flynn JL
    Nat Rev Immunol; 2017 Nov; 17(11):691-702. PubMed ID: 28736436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.